Harbour Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.81M Sell
22,237
-1,647
-7% -$217K 0.04% 437
2026
Q1
$3.33M Buy
23,884
+4,363
+22% +$611K 0.05% 343
2025
Q4
$2.4M Buy
19,521
+12,365
+173% +$1.5M 0.05% 344
2025
Q3
$794K Sell
7,156
-148
-2% -$16.8K 0.02% 643
2025
Q2
$810K Sell
7,304
-69
-0.9% -$7.34K 0.02% 597
2025
Q1
$826K Sell
7,373
-614
-8% -$63.4K 0.02% 540
2024
Q4
$738K Sell
7,987
-103
-1% -$9.27K 0.02% 575
2024
Q3
$678K Sell
8,090
-965
-11% -$73.6K 0.02% 564
2024
Q2
$621K Buy
9,055
+2,037
+29% +$136K 0.02% 543
2024
Q1
$514K Buy
7,018
+358
+5% +$27.5K 0.02% 583
2023
Q4
$540K Buy
6,660
+449
+7% +$34.9K 0.02% 513
2023
Q3
$466K Sell
6,211
-399
-6% -$30.7K 0.02% 501
2023
Q2
$509K Sell
6,610
-15
-0.2% -$1.2K 0.03% 491
2023
Q1
$550K Buy
6,625
+312
+5% +$25.8K 0.03% 447
2022
Q4
$542K Buy
6,313
+1,692
+37% +$134K 0.03% 434
2022
Q3
$286K Hold
4,621
0.02% 571
2022
Q2
$286K Buy
+4,621
New +$286K 0.02% 571
2021
Q4
$339K Sell
4,663
-9,836
-68% -$677K 0.02% 531
2021
Q3
$1.01M Sell
14,499
-2,448
-14% -$172K 0.03% 439
2021
Q2
$1.17M Buy
16,947
+2,731
+19% +$182K 0.04% 416
2021
Q1
$919K Buy
+14,216
New +$917K 0.03% 434

Other funds holding GILD

Harbour Investments's GILD Position: Q2 2026 in Review

Harbour Investments reduced its Gilead Sciences (GILD) stake by 6.9% in Q2 2026, selling an estimated $217K and leaving 22,237 shares worth $2.81M. The position accounts for 0.04% of the portfolio, ranked #437.

Harbour Investments first reported a position in GILD in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.33M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Harbour Investments held 22,237 shares of Gilead Sciences worth $2.81M as of Q2 2026.
  • Harbour Investments sold 1,647 Gilead Sciences shares in Q2 2026, an estimated $217K.
  • Gilead Sciences made up 0.04% of Harbour Investments's portfolio in Q2 2026, its #437 holding.
  • Harbour Investments first reported a position in Gilead Sciences in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's Gilead Sciences position peaked at $3.33M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.